echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JAMA Oncol: Individuals with ATM pathogenic variants are more than six times more likely to develop pancreatic cancer!

    JAMA Oncol: Individuals with ATM pathogenic variants are more than six times more likely to develop pancreatic cancer!

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pathogenic germline variants in the ATM gene are associated with the risk of pancreatic cancer


    Pancreatic cancer

    This study evaluated the age-specific penetrance of pancreatic cancer in individuals carrying pathogenic variants in the ATM gene


    This is a multicenter cohort study that analyzed pedigree data from 130 pancreatic cancer families carrying pathogenic germline ATM variants


    Pancreatic cancer occurrence in the test cohort

    Pancreatic cancer occurrence in the test cohort

    These 130 families (123 white families) consist of 2227 family members (average age 58 years, 1096 women) with complete records (family relationship, pancreatic cancer diagnosis , ATM status, proband status, and age), of which 155 There are 16 people who carry ATM pathogenic variants, 16 people do not carry ATM pathogenic variants , and other individuals have no test results


    Diagnosed 155 people with ATM pathogenic variants, 16 without ATM pathogenic variants, 155 with ATM pathogenic variants, and 16 without ATM pathogenic variants.


    Cumulative risk of pancreatic cancer in individuals with or without ATM pathogenic variants

    Cumulative risk of pancreatic cancer in individuals with or without ATM pathogenic variants

    The average age at diagnosis is 64 years (range 31-98 years)


    At the age of 50, the cumulative risk of pancreatic cancer for individuals carrying germline pathogenic ATM variants is estimated to be 1.


    Original source:

    Original source:

    Hsu F, Roberts NJ, Childs E, et al.


    Among the Individuals of Pancreatic Cancer Risk Pathogenic With the ATM Gene Variants The in JAMA

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.